Glenn Saldanha
Home
About Us
Structure
Current Events
Past Events
Policy & Reports
Awards
Membership
Media Coverage
Internship/Volunteers
Legal
Contact Us
 
 
Glenn Saldanha
Chairman & Managing Director
Glenmark Pharmaceuticals

As the Chairman and Managing Director of Glenmark Pharmaceuticals Ltd., Glenn Saldanha oversees the entire operations of the organization.

In 1998, Glenn decided to give up a promising career in the US and return back to India with an ambition to create something unique. Recognizing the enormous opportunity in the Indian Pharmaceutical Industry, he joined Glenmark and took over the operations as the CEO. During his tenure, Glenmark has been transformed into a truly global research-led organization with revenue in excess of Rs 9,000 crores (USD 1.4 billion) and offices in more than 50 countries worldwide. Glenmark’s branded generics presence is spread across five regions viz. Asia including India, Europe, Africa, Latin America and RCIS. Glenmark has also established itself among the Top 15 generics companies in the US and has built a sizeable API business in a short period. Presently, over 70% of Glenmark’s total turnover comes from the overseas operations.

During his tenure the biggest achievement for Glenmark has been its ability to discover best-in-class or first-in-class molecules for global development and unmet medical needs thus positioning Glenmark as a leader in drug discovery. Glenmark has managed to strike seven out licensing deals in innovative R&D with big pharmaceutical companies. Presently, Glenmark has a diverse pipeline with several compounds in various stages of clinical development primarily focused in the therapeutic areas of oncology, respiratory, and dermatology. Glenn’s vision is to discover, develop and take to market India’s first innovative drug for the entire world.

Glenn holds a Bachelor’s Degree in Pharmacy from Mumbai University and holds an MBA from Leonard Stern School of Business, New York University. Prior to Glenmark, he has worked with Eli Lily, USA and PricewaterhouseCoopers, USA.

Glenn was recognized as the 'EY Entrepreneur of the Year 2017' in Life Sciences & Healthcare category, India. In 2014, he was conferred with Best CEO: Pharma & Healthcare (mid-sized companies')’ by Business Today. Also in the same year he was among the ranking of ‘Top 50 CEOs in India’ by Entrepreneur Magazine. He was also conferred with the ‘Swiss Ambassador’s Award for Exceptional Innovation’ – Embassy of Switzerland in 2012 and was among the Top 30 Youth Icons of India’ 2012 by Hindustan Times.

© 2007 - USA India Chamber of Commerce Home | About us | Agenda | Council | Policy | Events | Photo Gallery | Awards | Membership | Membership Form | Internship/Volunteers | Legal | Contact us